News
ATRC
40.94
+3.41%
1.35
Atricure Files For Mixed Shelf; Size Not Disclosed
Benzinga · 11h ago
AtriCure files automatic mixed securities shelf
TipRanks · 11h ago
ATRICURE INC FILES FOR MIXED SHELF; SIZE NOT DISCLOSED - SEC FILING
Reuters · 11h ago
AtriCure’s Earnings Call Highlights Strong Growth and Positive Outlook
TipRanks · 1d ago
AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know
NASDAQ · 1d ago
AtriCure Price Target Raised to $45.00/Share From $36.00 by Oppenheimer
Dow Jones · 1d ago
AtriCure Is Maintained at Outperform by Oppenheimer
Dow Jones · 1d ago
Oppenheimer Maintains Outperform on AtriCure, Raises Price Target to $45
Benzinga · 1d ago
AtriCure Is Maintained at Overweight by Piper Sandler
Dow Jones · 1d ago
Piper Sandler Maintains Overweight on AtriCure, Raises Price Target to $50
Benzinga · 1d ago
AtriCure Price Target Maintained With a $60.00/Share by JMP Securities
Dow Jones · 1d ago
JMP Securities Reiterates Market Outperform on AtriCure, Maintains $60 Price Target
Benzinga · 1d ago
AtriCure Is Maintained at Buy by Stifel
Dow Jones · 1d ago
Stifel Maintains Buy on AtriCure, Raises Price Target to $48
Benzinga · 1d ago
ATRICURE <ATRC.O>: OPPENHEIMER RAISES TARGET PRICE TO $45 FROM $36
Reuters · 1d ago
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Kala Pharmaceuticals (KALA) and Tenet Healthcare (THC)
TipRanks · 1d ago
AtriCure price target raised to $48 from $36 at Stifel
TipRanks · 1d ago
AtriCure price target raised to $57 from $53 at BTIG
TipRanks · 1d ago
AtriCure price target raised to $50 from $40 at Piper Sandler
TipRanks · 1d ago
AtriCure Price Target Maintained With a $51.00/Share by Needham
Dow Jones · 1d ago
More
Webull provides a variety of real-time ATRC stock news. You can receive the latest news about Atricure through multiple platforms. This information may help you make smarter investment decisions.
About ATRC
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.